Vitamin D therapy in patients with chronic renal disease: the role of the renal dietitian.
Chronic renal failure causes decreased vitamin D production, which profoundly alters parathyroid hormone (PTH) metabolism, and calcium and phosphorus balance. Correcting this deficiency is an important strategy in managing secondary hyperparathyroidism (SHPT) and helping to restore mineral balance. However, hypercalcemia and hyperphosphatemia are common side effects that hamper vitamin D hormone therapy by increasing dietary calcium and phosphorus absorption. This limitation has led to the development of D-hormone analogs that retain the ability to suppress PTH levels without causing drastic changes in calcium and phosphorus metabolism. These analogs have the potential to advance the management of SHPT. Renal dietitians can play a leading role in ensuring successful management of SHPT by participating in early patient intervention for abnormal mineral and vitamin D metabolism, by encouraging long-term phosphorus control, and by updating and implementing clinical protocols that promote optimal hormone levels (D and PTH), mineral levels (phosphorus and calcium), and nutritional factors.
Sadler
R
R
Ochsner Clinic, New Orleans, LA 70121, USA.
D004046:Dietetics; D006801:Humans; D006934:Hypercalcemia / Q000178:diet therapy / Q000188:drug therapy; D006962:Hyperparathyroidism, Secondary / Q000178:diet therapy / Q000188:drug therapy; D007676:Kidney Failure, Chronic / Q000178:diet therapy* / Q000188:drug therapy*; D014807:Vitamin D / Q000627:therapeutic use*
D014807:Vitamin D